Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Intra-ovarian injection of bone marrow-derived c-Kit + cells for ovarian rejuvenation in menopausal rats

Sheshpari S., Shahnazi M., Ahmadian S., Nouri M., Mesgari Abbasi M., Beheshti R.

Animal Study on Hair & Scalp, Systemic / IV, published in Bioimpacts (2022) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Bioimpacts (2022)
Reported sample size
—
Source database
Europe PMC
PMID
35975202
PMCID
PMC9376162
DOI
10.34172/bi.2021.23499
Citations
16

Abstract (original English)

Introduction: Cell-based therapies with certain cell types are touted as novel and hopeful therapeutic intervention in the clinical setting. Here, we aimed to assess the regenerative potential of c-Kit + cells in the rejuvenation of ovarian tissue and fertility rate in rat model of premature ovarian failure (POF). Methods: Rats were treated with 160 mg/kg/BW of 4-vinylcyclohexene dioxide for 15 days. Freshly enriched rat bone marrow-derived c-Kit + (MACS) and c-Kit - cells (4×10 5 cells/10 µL) were transplanted into the ovaries of treatment and control animals. Prior to transplantation as well as 2, 4, 6, and 8 weeks post-transplantation, randomly-selected rats were euthanized and ovarian tissues were subjected to pathophysiological examinations and real-time PCR analyses. Results: POF status was confirmed by the presence of pathological features and a decreased number of immature and mature follicles compared with the control group ( P + cells in comparison with POF rats that did not receive these cells ( P Angpt2 and KDR , showed increased and decreased expressions in POF ovaries, respectively ( P + cells had potential to restore angiogenesis in the ovarian tissue within normal ranges. Systemic levels of FSH did not significantly change in pre- or post-transplantation time points for any group ( P > 0.05). Notable reduction of collagen deposition was found in c-Kit-treated ra

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research